S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SONN Sonnet BioTherapeutics Holdings Inc

1.57

-0.06 (-3.68%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics Holdings Inc News

Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
Tuesday 28 May 2024 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 22 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Friday 17 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 17 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Thursday 16 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 11 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

More Sonnet BioTherapeutics Holdings Inc News Articles

Vontobel Financial Produ...

Societe Generale Mtn Bd0...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions